dr. pacheco on second-line therapy for alk nsclc
Published 6 years ago • 246 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
8:24
second-line treatment for alk-positive nsclc
-
8:24
second-line treatment for alk-positive nsclc
-
8:55
choosing second-line therapy for alk nsclc
-
4:43
upfront therapy for alk/ros1-rearranged nsclc
-
1:47
dr. pacheco on frontline therapy for patients with egfr-mutant nsclc
-
3:06
selecting second-line therapy for alk nsclc
-
1:34
second-line treatments in alk-rearranged nsclc
-
0:45
slcvl - hunis - #12 second line therapy for nsclc and alk
-
8:09
second-line therapy in alk nsclc
-
3:59
second-line treatment for nondriver metastatic nsclc
-
4:14
should a second generation alk inhibitor be first line therapy for patients with alk-positive nsclc?
-
4:31
alk-positive nsclc: alex trial
-
1:41
typical response, progression, and second-line therapy for nsclc
-
3:13
available therapies for alk-rearranged nsclc
-
0:44
alk-tkis: targeted therapies for alk-positive nsclc
-
22:10
first and second generation alk inhibitors for the treatment of lung cancer
-
5:30
sequencing therapy in alk/ros1-rearranged nsclc
-
1:52
dr. shaw on crizotinib versus chemotherapy in alk-positive nsclc
-
1:14
dr. halmos on second-line treatment in metastatic squamous nsclc